146 related articles for article (PubMed ID: 1468690)
1. Lymph node sampling in patients with epithelial ovarian carcinoma.
Goldberg GL; Scheiner J; Friedman A; O'Hanlan KA; Davidson SA; Runowicz CD
Gynecol Oncol; 1992 Nov; 47(2):143-5. PubMed ID: 1468690
[TBL] [Abstract][Full Text] [Related]
2. [Significance of lymphadenectomy in patients with epithelial ovarian cancer at second exploratory operation].
Wang JD; Zhang WH; Wu LY; Liu LY; Zhang R; Li HJ
Ai Zheng; 2002 Mar; 21(3):289-91. PubMed ID: 12451997
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
4. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
Yavuzcan A; Baloglu A; Cetinkaya B
Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer.
Eisenkop SM; Spirtos NM
Gynecol Oncol; 2001 Jul; 82(1):143-9. PubMed ID: 11426976
[TBL] [Abstract][Full Text] [Related]
6. Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation.
Pereira A; Irishina N; Pérez-Medina T; Magrina JF; Magtibay PM; Kovaleva A; Rodríguez-Tapia A; Iglesias E
Eur J Surg Oncol; 2013 Mar; 39(3):290-6. PubMed ID: 23290581
[TBL] [Abstract][Full Text] [Related]
7. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
[TBL] [Abstract][Full Text] [Related]
9. The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy.
Signorelli M; Fruscio R; Ceppi L; Dell'anna T; Vitobello D; Chiappa V; Siesto G; Milani R; Landoni F; Mangioni C
Gynecol Oncol; 2014 Feb; 132(2):312-5. PubMed ID: 24423881
[TBL] [Abstract][Full Text] [Related]
10. Correlation of abdominal computed tomography scanning and second-look operation findings in ovarian cancer patients.
Pectasides D; Kayianni H; Facou A; Bobotas N; Barbounis V; Zis J; Athanassiou A
Am J Clin Oncol; 1991 Dec; 14(6):457-62. PubMed ID: 1957833
[TBL] [Abstract][Full Text] [Related]
11. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer.
Pereira A; Magrina JF; Rey V; Cortes M; Magtibay PM
Gynecol Oncol; 2007 Jun; 105(3):604-8. PubMed ID: 17321572
[TBL] [Abstract][Full Text] [Related]
12. Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer.
Baiocchi G; Grosso G; di Re E; Fontanelli R; Raspagliesi F; di Re F
Gynecol Oncol; 1998 May; 69(2):151-6. PubMed ID: 9600823
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the role of second-look surgery in ovarian cancer.
Chambers SK; Chambers JT; Kohorn EI; Lawrence R; Schwartz PE
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):404-8. PubMed ID: 3405557
[TBL] [Abstract][Full Text] [Related]
14. The effect of chemotherapy on lymph node metastases in ovarian cancer.
Burghardt E; Winter R
Baillieres Clin Obstet Gynaecol; 1989 Mar; 3(1):167-71. PubMed ID: 2661090
[TBL] [Abstract][Full Text] [Related]
15. [Second-look and third-look laparotomies in follow-up of ovarian cancer. A critical review of 6 years' experience].
Schneider J; Erasun F; Hervas JL; Miñambres JL
Zentralbl Gynakol; 1987; 109(4):235-42. PubMed ID: 3591059
[TBL] [Abstract][Full Text] [Related]
16. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
Aletti GD; Dowdy S; Podratz KC; Cliby WA
Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488
[TBL] [Abstract][Full Text] [Related]
17. The effect of platinum-based combination chemotherapy on the lymph nodes in advanced-stage epithelial ovarian cancer: does it decrease the incidence of lymph node involvement?
Simsek T; Simsek M; Pesterelli E; Karaveli S; Trak B
J Obstet Gynaecol; 2002 Nov; 22(6):666-8. PubMed ID: 12554260
[TBL] [Abstract][Full Text] [Related]
18. [A rational treatment of stage I epithelial ovarian cancer].
Wang W; Huo R
Zhonghua Fu Chan Ke Za Zhi; 1996 Jul; 31(7):387-9. PubMed ID: 9275407
[TBL] [Abstract][Full Text] [Related]
19. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
Berek JS
Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma.
Salani R; Diaz-Montes T; Giuntoli RL; Bristow RE
Ann Surg Oncol; 2007 Dec; 14(12):3552-7. PubMed ID: 17896149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
